Enzomac (Typsin, Bromelain & Rutoside Trihydrate) TabletsFitness Equipment
Enzomac (Typsin, Bromelain & Rutoside Trihydrate) Tablets
Trpsin BP 48 Mg
Bromelain 90 Mg
Rutoside Trihydrate BP 100 Mg
Total proteolytic activity not less than 1095 FIP units per tablet. (Papain method).
Description- Enzomac contains a combination of two proteolytic enzymes Typsin and Bromelain together with plant flavonoid Rutoside. This combination has anti-inflammatory properties.
Indications- Enzomac is indicated for treatment of edema and inflammation of traumatic origin such as contusions, lacerations and cuts. It is also indicated for treatment of edema and inflammation following surgery, tooth extraction, cellulitis, abscess, sport injuries and sprains. Enzomac is indicated for inflammatory episodes of rheumatic and degenerative conditions, such as Rheumatoid Arthritis, osteoarthritis, Spondylopathies, Tendonitis and Bursitis.
Dosage- 6 tablets of Enzomac , 2 tablets three times a day, are recommended for adult patients.
Children: (6 years and above) 1 tablet/ 10kg body weight/ day up to maximum 6 tablets a day. Total recommended dose is administered in 2-3 divided doses.
Enzomac side effects:
Enzomac is usually well tolerated. Harmless alteration in the consistency, color and odor of stool may occur. A sensation of fullness, flatulence, and occasional episodes of nausea are possible during high- dosage administration. They can be avoided by administration of the enzyme preparation in divided doses during a day. If these symptoms persist doctor should be consulted. Allergic reaction occurs rarely and disappears after the discontinuation of the drug. In case of their occurrence discontinue using Enzomac and doctor should be consulted.
No clinical trials have been conducted to evaluate the drug interaction of Enzomac. However, no evidence of incompatibility of Enzomac with other simultaneously administered drugs have been reported.
Enzomac must not be used in case of known hypersensitivity to its active ingredients. The preparation must not be used by patients with severe inborn or gained coagulation disorders. (E.g- hemophilia, severe liver damage, dialyzed patients).
Children: recommended dose is 1 tablet/ 10 kg body weight per day. Total recommended dose is administered in 2-3 divides doses. Therefore the minimum weight of the patient should be 20 kg, which corresponds to approximately 6 years.
Pregnancy and Lactation:
Administration of Enzomac during pregnancy and breastfeeding is not recommended.
Store in a cool and dry place away from direct sunlight.
You may also be interested in